BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kroemer A, Khan K, Plassmeyer M, Alpan O, Haseeb MA, Gupta R, Fishbein TM. Inflammasome activation and pyroptosis in lymphopenic liver patients with COVID-19. J Hepatol 2020;73:1258-62. [PMID: 32645361 DOI: 10.1016/j.jhep.2020.06.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Premeaux TA, Yeung ST, Bukhari Z, Bowler S, Alpan O, Gupta R, Ndhlovu LC. Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies. Front Immunol 2022;13:842740. [DOI: 10.3389/fimmu.2022.842740] [Reference Citation Analysis]
2 Wissler Gerdes EO, Vanichkachorn G, Verdoorn BP, Hanson GJ, Joshi AY, Murad MH, Rizza SA, Hurt RT, Tchkonia T, Kirkland JL. Role of senescence in the chronic health consequences of COVID-19. Transl Res 2021:S1931-5244(21)00259-0. [PMID: 34695606 DOI: 10.1016/j.trsl.2021.10.003] [Reference Citation Analysis]
3 Plassmeyer M, Alpan O, Corley MJ, Premeaux TA, Lillard K, Coatney P, Vaziri T, Michalsky S, Pang APS, Bukhari Z, Yeung ST, Evering TH, Naughton G, Latterich M, Mudd P, Spada A, Rindone N, Loizou D, Ulrik Sønder S, Ndhlovu LC, Gupta R. Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID. Allergy 2021. [PMID: 33993490 DOI: 10.1111/all.14907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Middleton P, Hsu C, Lythgoe MP. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. BMJ Open Gastroenterol 2021;8:e000739. [PMID: 34675033 DOI: 10.1136/bmjgast-2021-000739] [Reference Citation Analysis]
5 Xu L, Lin L, Lu X, Xiao P, Liu R, Wu M, Jin M, Zhang A. Acquiring high expression of suilysin enable non-epidemic Streptococccus suis to cause streptococcal toxic shock-like syndrome (STSLS) through NLRP3 inflammasome hyperactivation. Emerg Microbes Infect 2021;10:1309-19. [PMID: 33792531 DOI: 10.1080/22221751.2021.1908098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ma D, Yang B, Guan B, Song L, Liu Q, Fan Y, Zhao L, Wang T, Zhang Z, Gao Z, Li S, Xu H. A Bibliometric Analysis of Pyroptosis From 2001 to 2021. Front Immunol 2021;12:731933. [PMID: 34484243 DOI: 10.3389/fimmu.2021.731933] [Reference Citation Analysis]
7 Cui H, Zhang L. Key Components of Inflammasome and Pyroptosis Pathways Are Deficient in Canines and Felines, Possibly Affecting Their Response to SARS-CoV-2 Infection. Front Immunol 2020;11:592622. [PMID: 33584656 DOI: 10.3389/fimmu.2020.592622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Brain D, Plant-Hately A, Heaton B, Arshad U, David C, Hedrich C, Owen A, Liptrott NJ. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Adv Drug Deliv Rev 2021;:113848. [PMID: 34182016 DOI: 10.1016/j.addr.2021.113848] [Reference Citation Analysis]
9 Saeedi-Boroujeni A, Mahmoudian-Sani MR, Nashibi R, Houshmandfar S, Tahmaseby Gandomkari S, Khodadadi A. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacol Immunotoxicol 2021;43:247-58. [PMID: 34015982 DOI: 10.1080/08923973.2021.1925293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Alfaro E, Díaz-garcía E, García-tovar S, Zamarrón E, Mangas A, Galera R, López-collazo E, García-rio F, Cubillos-zapata C. Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation. Biomolecules 2022;12:442. [DOI: 10.3390/biom12030442] [Reference Citation Analysis]
11 Ashokkumar C, Rohan V, Kroemer AH, Rao S, Mazariegos G, Higgs BW, Nadig S, Almeda J, Dhani H, Khan K, Yazigi N, Ekong U, Kaufman S, Betancourt-Garcia MM, Mukund K, Sethi P, Mehrotra S, Soltys K, Singh MS, Bond G, Khanna A, Ningappa M, Spishock B, Sindhi E, Atale N, Saunders M, Baliga P, Fishbein T, Subramaniam S, Sindhi R. Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients. bioRxiv 2021:2021. [PMID: 33972936 DOI: 10.1101/2021.05.03.442371] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bombaci G, Sarangdhar MA, Andina N, Tardivel A, Yu EC, Mackie GM, Pugh M, Ozan VB, Banz Y, Spinetti T, Hirzel C, Youd E, Schefold JC, Taylor G, Gazdhar A, Bonadies N, Angelillo-scherrer A, Schneider P, Maslowski KM, Allam R. LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity. Life Sci Alliance 2022;5:e202101226. [DOI: 10.26508/lsa.202101226] [Reference Citation Analysis]
13 Cheon SY, Koo BN. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2. Int J Mol Sci 2021;22:7914. [PMID: 34360684 DOI: 10.3390/ijms22157914] [Reference Citation Analysis]